{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:01:59Z","timestamp":1789966919110,"version":"4.0.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD094629"],"award-info":[{"award-number":["R01HD094629"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"DOI":"10.1007\/s10461-026-05262-8","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:00:23Z","timestamp":1789963223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pre-exposure Prophylaxis Outcomes from a Multilevel Cluster-Randomized Trial Among Adolescent Girls and Young Women in Tshwane, South Africa"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6983-2698","authenticated-orcid":false,"given":"Courtney Peasant","family":"Bonner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M.","family":"Minnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia A.","family":"Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilene S.","family":"Speizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Nyblade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline W.","family":"Ndirangu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy L.","family":"Kline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayanna","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khatija","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendee M.","family":"Wechsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"5262_CR1","unstructured":"UNAIDS, Country factsheets. South Africa 2023 HIV and AIDS estimates 2023. Available from: https:\/\/www.unaids.org\/en\/regionscountries\/countries\/southafrica"},{"key":"5262_CR2","unstructured":"UNAIDS. Progress towards the Start Free, Stay Free, AIDS Free targets 2020. Available from: https:\/\/www.unaids.org\/en\/resources\/documents\/2020\/start-free-stay-free-aids-free-2020-progress-report"},{"key":"5262_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/1874613601610010034","volume":"10","author":"AB Kharsany","year":"2016","unstructured":"Kharsany AB, Karim QA. HIV infection and AIDS in sub-Saharan Africa: current status, challenges and opportunities. Open AIDS J. 2016;10:34\u201348. https:\/\/doi.org\/10.2174\/1874613601610010034.","journal-title":"Open AIDS J"},{"issue":"13","key":"5262_CR4","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa2407001","volume":"391","author":"LG Bekker","year":"2024","unstructured":"Bekker LG, Das M, Abdool Karim Q, Ahmed K, Batting J, Brumskine W, et al. Twice-yearly lenacapavir or daily F\/TAF for HIV prevention in cisgender women. N Engl J Med. 2024;391(13):1179\u201392. https:\/\/doi.org\/10.1056\/NEJMoa2407001.","journal-title":"N Engl J Med"},{"key":"5262_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113849","volume":"176","author":"SA Krovi","year":"2021","unstructured":"Krovi SA, Johnson LM, Luecke E, Achilles SL, van der Straten A. Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention. Adv Drug Deliv Rev. 2021;176:113849.","journal-title":"Adv Drug Deliv Rev"},{"issue":"10337","key":"5262_CR6","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0140-6736(22)00538-4","volume":"399","author":"S Delany-Moretlwe","year":"2022","unstructured":"Delany-Moretlwe S, Hughes JP, Bock P, Ouma SG, Hunidzarira P, Kalonji D, et al. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. Lancet. 2022;399(10337):1779\u201389.","journal-title":"Lancet"},{"key":"5262_CR7","unstructured":"Republic of South Africa Department of Health. National policy on HIV pre-exposure prophylaxis (PrEP) and test and treat. T&T); 2016."},{"issue":"22","key":"5262_CR8","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","volume":"375","author":"A Nel","year":"2016","unstructured":"Nel A, van Niekerk N, Kapiga S, Bekker LG, Gama C, Gill K, et al. Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women. N Engl J Med. 2016;375(22):2133\u201343.","journal-title":"N Engl J Med"},{"key":"5262_CR9","unstructured":"National Department of Health. National dapivirine ring implementation guidelines. 2022."},{"key":"5262_CR10","unstructured":"Republic of South Africa Department of Health. Guidelines for the provision of pre-exposure prophylaxis (PrEP) to persons at substantial risk of HIV infection. 2020."},{"key":"5262_CR11","unstructured":"South Africa National Department of Health. Pre-exposure prophylaxis (PrEP): lenacapavir implementation guidelines. 2025."},{"key":"5262_CR12","unstructured":"South Africa National Department of Health. National implementation guidelines for long-acting injectable cabotegravir (CAB-LA). 2024."},{"issue":"11","key":"5262_CR13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.7196\/SAMJ.2015.v105i11.10222","volume":"105","author":"LG Bekker","year":"2015","unstructured":"Bekker LG, Gill K, Wallace M. Pre-exposure prophylaxis for South African adolescents: what evidence? S Afr Med J. 2015;105(11):907\u201311.","journal-title":"S Afr Med J"},{"key":"5262_CR14","unstructured":"Geneva US. Mission to International Organizations. PEPFAR, Gates and Nike Foundations partner to reduce new HIV infections in adolescent girls and young women. 2014."},{"key":"5262_CR15","doi-asserted-by":"publisher","first-page":"e0208167","DOI":"10.1371\/journal.pone.0208167","volume":"13","author":"J Saul","year":"2018","unstructured":"Saul J, Bachman G, Allen S, Toiv NF, Cooney C, Beamon T. The DREAMS core package of interventions. PLoS ONE. 2018;13:e0208167.","journal-title":"PLoS ONE"},{"issue":"Suppl 4","key":"5262_CR16","doi-asserted-by":"publisher","first-page":"e25298","DOI":"10.1002\/jia2.25298","volume":"22","author":"CL Celum","year":"2019","unstructured":"Celum CL, Delany-Moretlwe S, Baeten JM, van der Straten A, Hosek S, Bukusi EA, et al. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa. J Int AIDS Soc. 2019;22(Suppl 4):e25298.","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"5262_CR17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/QAI.0000000000000158","volume":"66","author":"AL Corneli","year":"2014","unstructured":"Corneli AL, Deese J, Wang M, Taylor D, Ahmed K, Agot K, et al. FEM-PrEP adherence patterns and factors. J Acquir Immune Defic Syndr. 2014;66(3):324\u201331.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"5262_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509\u201318.","journal-title":"N Engl J Med"},{"key":"5262_CR19","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/1471-2458-13-482","volume":"13","author":"S Baral","year":"2013","unstructured":"Baral S, Logie CH, Grosso A, Wirtz AL, Beyrer C. Modified social ecological model. BMC Public Health. 2013;13:482.","journal-title":"BMC Public Health"},{"key":"5262_CR20","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1007\/s10461-020-03145-0","volume":"25","author":"S O\u2019Rourke","year":"2021","unstructured":"O\u2019Rourke S, Hartmann M, Myers L, Lawrence N, Gill K, Morton JF, et al. The PrEP journey. AIDS Behav. 2021;25:2154\u201365.","journal-title":"AIDS Behav"},{"key":"5262_CR21","doi-asserted-by":"publisher","first-page":"e0281728","DOI":"10.1371\/journal.pone.0281728","volume":"18","author":"G Beauchamp","year":"2023","unstructured":"Beauchamp G, Hosek S, Donnell DJ, Chan KCG, Flaherty BP, Anderson PL, et al. PrEP readiness tool. PLoS ONE. 2023;18:e0281728.","journal-title":"PLoS ONE"},{"key":"5262_CR22","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s10508-020-01880-y","volume":"50","author":"R Muhumuza","year":"2021","unstructured":"Muhumuza R, Ssemata AS, Kakande A, Ahmed N, Atujuna M, Nomvuyo M, et al. Barriers and facilitators of PrEP uptake. Arch Sex Behav. 2021;50:1729\u201342.","journal-title":"Arch Sex Behav"},{"key":"5262_CR23","doi-asserted-by":"publisher","first-page":"e0258542","DOI":"10.1371\/journal.pone.0258542","volume":"16","author":"E Rousseau","year":"2021","unstructured":"Rousseau E, Katz AWK, O\u2019Rourke S, Bekker LG, Delany-Moretlwe S, Bukusi E, et al. AGYW PrEP-user journey. PLoS ONE. 2021;16:e0258542.","journal-title":"PLoS ONE"},{"key":"5262_CR24","doi-asserted-by":"publisher","first-page":"1073103","DOI":"10.3389\/frph.2023.1073103","volume":"5","author":"E Rousseau","year":"2023","unstructured":"Rousseau E, Wu L, Heffron R, Baeten JM, Celum CL, Travill D, et al. Sexual relationship power and PrEP persistence. Front Reprod Health. 2023;5:1073103.","journal-title":"Front Reprod Health"},{"key":"5262_CR25","doi-asserted-by":"publisher","first-page":"e25463","DOI":"10.1002\/jia2.25463","volume":"23","author":"J Velloza","year":"2020","unstructured":"Velloza J, Khoza N, Scorgie F, Chitukuta M, Mutero P, Mutiti K, et al. HIV-related stigma and PrEP adherence. J Int AIDS Soc. 2020;23:e25463.","journal-title":"J Int AIDS Soc"},{"key":"5262_CR26","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s40265-019-01143-8","volume":"79","author":"I Hodges-Mameletzis","year":"2019","unstructured":"Hodges-Mameletzis I, Fonner VA, Dalal S, Mugo N, Msimanga-Radebe B, Baggaley R. PrEP for women. Drugs. 2019;79:1263\u201376.","journal-title":"Drugs"},{"key":"5262_CR27","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1186\/s12889-020-09458-y","volume":"20","author":"WM Wechsberg","year":"2020","unstructured":"Wechsberg WM, Browne FA, Ndirangu J, Bonner CP, Minnis AM, Nyblade L, et al. PrEPARE Pretoria protocol. BMC Public Health. 2020;20:1403.","journal-title":"BMC Public Health"},{"key":"5262_CR28","unstructured":"Kidd R, Clay S, Stockton M, Nyblade L. Facilitator\u2019s training guide. 2015."},{"key":"5262_CR29","unstructured":"Nyblade L, Stewart C, Kiwia P, Manyama W, Mbuya-Brown R, Bowsky S. Stigma-free health facilities guide. 2019."},{"issue":"suppl 2","key":"5262_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/09540121.2020.1739221","volume":"32","author":"ML Ekstrand","year":"2020","unstructured":"Ekstrand ML, Raj T, Heylen E, Nyblade L, Devdass D, Pereira M, et al. DriSti trial. AIDS Care. 2020;32(suppl 2):14\u201322.","journal-title":"AIDS Care"},{"key":"5262_CR31","doi-asserted-by":"publisher","first-page":"e25483","DOI":"10.1002\/jia2.25483","volume":"23","author":"L Nyblade","year":"2020","unstructured":"Nyblade L, Addo NA, Atuahene K, Alsoufi N, Gyamera E, Jacinthe S, et al. Stigma reduction interventions in Ghana. J Int AIDS Soc. 2020;23:e25483.","journal-title":"J Int AIDS Soc"},{"key":"5262_CR32","unstructured":"Nyblade L, Mbuya-Brown R, Sabasaba A, Ezekiel M, Kiwia P, Stewart C. HIV stigma toolkit. 2018."},{"key":"5262_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fpubh.2018.00165","volume":"6","author":"L Nyblade","year":"2018","unstructured":"Nyblade L, Srinivasan K, Mazur A, Raj T, Patil DS, Devadass D, et al. Blended-learning stigma intervention. Front Public Health. 2018;6:165.","journal-title":"Front Public Health"},{"key":"5262_CR34","doi-asserted-by":"publisher","first-page":"2340500","DOI":"10.1080\/17441692.2024.2340500","volume":"19","author":"WM Wechsberg","year":"2024","unstructured":"Wechsberg WM, Browne FA, Carney T, Kline TL, Howard BN, Russell SE, et al. Structural and cultural differences AGYW. Glob Public Health. 2024;19:2340500.","journal-title":"Glob Public Health"},{"key":"5262_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-publhealth-032315-021702","volume":"37","author":"CM Crespi","year":"2016","unstructured":"Crespi CM. Cluster randomized trials. Annu Rev Public Health. 2016;37:1\u201316.","journal-title":"Annu Rev Public Health"},{"key":"5262_CR36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.adolescence.2021.11.001","volume":"93","author":"CP Bonner","year":"2021","unstructured":"Bonner CP, Fisher CB, Carney T, Browne FA, Gichane MW, Howard BN, et al. In loco parentis consent procedure. J Adolesc. 2021;93:234\u201344.","journal-title":"J Adolesc"},{"key":"5262_CR37","volume-title":"Revised risk behavior assessment, part I and part II","author":"WM Wechsberg","year":"1998","unstructured":"Wechsberg WM. Revised risk behavior assessment, part I and part II. Research Triangle Park: Research Triangle Institute; 1998."},{"key":"5262_CR38","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/cpt.2845","volume":"113","author":"AS Devanathan","year":"2023","unstructured":"Devanathan AS, Dumond JB, Anderson DJC, Moody K, Poliseno AJ, Schauer AP, et al. PrEP adherence algorithm. Clin Pharmacol Ther. 2023;113:896\u2013903.","journal-title":"Clin Pharmacol Ther"},{"key":"5262_CR39","doi-asserted-by":"crossref","first-page":"e01710","DOI":"10.1128\/AAC.01710-17","volume":"62","author":"PL Anderson","year":"2018","unstructured":"Anderson PL, Liu AY, Castillo-Mancilla JR, Gardner EM, Seifert SM, McHugh C, et al. DBS pharmacologic monitoring. Antimicrob Agents Chemother. 2018;62:e01710\u201317.","journal-title":"Antimicrob Agents Chemother"},{"key":"5262_CR40","doi-asserted-by":"crossref","first-page":"20642","DOI":"10.7448\/IAS.19.1.20642","volume":"19","author":"A van der Straten","year":"2016","unstructured":"van der Straten A, Brown ER, Marrazzo JM, Chirenje MZ, Liu K, Gomez K, et al. VOICE adherence measures. J Int AIDS Soc. 2016;19:20642.","journal-title":"J Int AIDS Soc"},{"key":"5262_CR41","unstructured":"South African National AIDS Council. National Strategic Plan for HIV, TB and STIs (2017\u20132022). 2017."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05262-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-026-05262-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05262-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:00:30Z","timestamp":1789963230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-026-05262-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":41,"alternative-id":["5262"],"URL":"https:\/\/doi.org\/10.1007\/s10461-026-05262-8","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"22 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}